METHODS FOR TREATING LIVER CANCERS USING AN ORALLY ADMINISTERED DIOXOLANE NUCLEOTIDE IN COMBINATION WITH AN ANTI-PD1 OR ANTI-PDL1 MONOCLONAL ANTIBODY

摘要

Use of a compound of the formula (I): or a pharmaceutically acceptable salt thereof, in the therapy of a liver cancer in a mammal, characterized by the concurrent or sequential treatment of the mammal with a monoclonal antibody which blocks the binding of PD-L1 and/or PD-L2 to PD-1.